Sex (male)
|
191 (69%)
|
185 (67%)
|
0.6
|
Age (years, mean +/-SD)
|
63 +/- 6
|
65 +/- 7
|
0.14
|
BMI (kg/m2, mean +/-SD)
|
31 +/- 4
|
30 +/- 4
|
0.5
|
Type of AF
|
|
|
0.7
|
Paroxysmal
|
235 (85%)
|
232 (84%)
|
|
Persistent
|
40 (15%)
|
43 (16%)
|
|
Coronary Artery Disease (%)
|
51 (19%)
|
52 (19%)
|
>0.9
|
Diabetes Mellitus (%)
|
49 (18%)
|
44 (16%)
|
0.6
|
Hypertension (%)
|
155 (56%)
|
162 (59%)
|
0.5
|
Obstructive Sleep Apnea (%)
|
55 (20%)
|
53 (19%)
|
0.8
|
Pre-procedure antiarrhythmic use
|
165 (61%)
|
200 (73%)
|
0.003
|
Procedural Details |
|
|
|
CTI dependent Atrial Flutter
|
54 (20%)
|
63 (23%)
|
0.3
|
Additional Ablations Performed
|
120 (44%)
|
202 (73%)
|
<0.001
|
Adenosine Used to Check for Dormant Conduction
|
188 (69%)
|
167 (61%)
|
0.053
|
Post-procedure Amiodarone use
|
89 (32%)
|
152 (55%)
|
<0.001
|
Post-procedure Dronederone use
|
18 (6.5%)
|
25 (9.1%)
|
0.3
|